Untaaveesup, S.; Kantagowit, P.; Ungprasert, P.; Kitlertbanchong, N.; Vajiraviroj, T.; Sutithavinkul, T.; Techataweewan, G.; Eiumtrakul, W.; Threethrong, R.; Chaemsupaphan, T.;
et al. The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis. J. Clin. Med. 2025, 14, 1374.
https://doi.org/10.3390/jcm14041374
AMA Style
Untaaveesup S, Kantagowit P, Ungprasert P, Kitlertbanchong N, Vajiraviroj T, Sutithavinkul T, Techataweewan G, Eiumtrakul W, Threethrong R, Chaemsupaphan T,
et al. The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025; 14(4):1374.
https://doi.org/10.3390/jcm14041374
Chicago/Turabian Style
Untaaveesup, Suvijak, Piyawat Kantagowit, Patompong Ungprasert, Nitchanan Kitlertbanchong, Tanyatorn Vajiraviroj, Tanpichcha Sutithavinkul, Gynna Techataweewan, Wongsathorn Eiumtrakul, Rinrada Threethrong, Thanaboon Chaemsupaphan,
and et al. 2025. "The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 14, no. 4: 1374.
https://doi.org/10.3390/jcm14041374
APA Style
Untaaveesup, S., Kantagowit, P., Ungprasert, P., Kitlertbanchong, N., Vajiraviroj, T., Sutithavinkul, T., Techataweewan, G., Eiumtrakul, W., Threethrong, R., Chaemsupaphan, T., Pratchyapruit, W., & Sriphrapradang, C.
(2025). The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 14(4), 1374.
https://doi.org/10.3390/jcm14041374
